Dr Reddy’s Laboratories announced on Friday that it has launched a generic medication in the US market
By The Capital
On
Dr Reddy’s Laboratories announced on Friday that it has launched a generic medication in the US market. The medication is used to treat a wide variety of bacterial…
Dr Reddy’s Laboratories announced on Friday that it has launched a generic medication in the US market. The medication is used to treat a wide variety of bacterial infections and is called Doxycycline Capsules (40 mg). According to the Hyderabad-based drug maker, their product is a therapeutic generic equivalent of Oracea capsules (40 mg) approved by the US Food and Drug Administration (USFDA). On Friday, the company’s shares ended 0.71 per cent up at Rs 6,332.85 apiece on the BSE.
Tags
Latest Posts
24 Apr 2025
The rupee depreciated 22 paise to 85.67 against the US dollar in early trade on Thursday, weighed down by negative...